CareTrust REIT price target raised to $43 from $41 at Jefferies

Jefferies raised the firm’s price target on CareTrust REIT (CTRE) to $43 from $41 and keeps a Buy rating on the shares as part of a broader research note previewing 2026 for Healthcare REITs. The company has the strongest operator bench in the peer group, as evidenced by robust rent coverage, limited operator restructurings during the pandemic, and no key operators on the firm’s watch list, which limits the probability of future operator deferrals – a key risk associated with CareTrust and its peers, the analyst tells investors in a research note. The REIT’s liquidity profile and low cost of capital are competitive advantages vs. its peers, the firm added.